GSK Plc (GSK)
48.27
-0.47
(-0.96%)
USD |
NYSE |
Oct 29, 11:05
GSK Total Return Level : 185.87 for Oct. 28, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 28, 2026 | 185.87 |
| October 27, 2026 | 194.26 |
| October 26, 2026 | 194.87 |
| October 23, 2026 | 193.53 |
| October 22, 2026 | 195.29 |
| October 21, 2026 | 190.75 |
| October 20, 2026 | 193.07 |
| October 19, 2026 | 188.61 |
| October 16, 2026 | 188.80 |
| October 15, 2026 | 186.94 |
| October 14, 2026 | 182.55 |
| October 13, 2026 | 176.45 |
| October 12, 2026 | 178.93 |
| October 09, 2026 | 177.33 |
| October 08, 2026 | 177.48 |
| October 07, 2026 | 179.31 |
| October 06, 2026 | 177.71 |
| October 05, 2026 | 177.52 |
| October 02, 2026 | 179.35 |
| October 01, 2026 | 179.92 |
| September 30, 2026 | 183.69 |
| September 29, 2026 | 188.19 |
| September 28, 2026 | 189.53 |
| September 25, 2026 | 187.77 |
| September 24, 2026 | 189.34 |
| Date | Value |
|---|---|
| September 23, 2026 | 189.57 |
| September 22, 2026 | 193.42 |
| September 21, 2026 | 194.79 |
| September 18, 2026 | 191.51 |
| September 17, 2026 | 194.71 |
| September 16, 2026 | 191.78 |
| September 15, 2026 | 190.71 |
| September 14, 2026 | 190.86 |
| September 11, 2026 | 183.54 |
| September 10, 2026 | 183.50 |
| September 09, 2026 | 185.45 |
| September 08, 2026 | 185.10 |
| September 04, 2026 | 190.25 |
| September 03, 2026 | 193.99 |
| September 02, 2026 | 192.35 |
| September 01, 2026 | 193.19 |
| August 31, 2026 | 191.63 |
| August 28, 2026 | 193.80 |
| August 27, 2026 | 191.70 |
| August 26, 2026 | 196.13 |
| August 25, 2026 | 198.57 |
| August 24, 2026 | 197.46 |
| August 21, 2026 | 199.86 |
| August 20, 2026 | 198.15 |
| August 19, 2026 | 201.65 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AstraZeneca PLC | 427.87 |
| Johnson & Johnson | 646.76 |
| Eli Lilly & Co. | 3403.96 |
| Merck & Co., Inc. | 435.81 |
| Novo Nordisk A/S | 68.52 |